Help Stem Cell Innovations
Business Services · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Nanjing, Jiangsu, ChinaWebsite
www.helpsci.com.cnRevenue
$13.6 MillionIndustry
About Help Stem Cell Innovations
Help Stem Cell Innovations Org Chart
Chief Financial Officer
Is Help Stem Cell Innovations your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Help Stem Cell Innovations, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Help Stem Cell Innovations recently announced quarterly report
Funding: Get notified immidiatlly once Help Stem Cell Innovations has new funding data
Congratulate Masked Content for being promoted to Masked Content at Help Stem Cell Innovations
Check out if Help Stem Cell Innovations is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Help Stem Cell Innovations had a recent Job posting/layoffs
Check if Help Stem Cell Innovations has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Help Stem Cell Innovations launches new products
Recommended Actions
Reach out to Masked Content who joined Help Stem Cell Innovations as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Help Stem Cell Innovations is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Help Stem Cell Innovations is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Help Stem Cell Innovations.
Help Stem Cell Innovations Tech Stack
A closer look at the technologies used by Help Stem Cell Innovations
Help Stem Cell Innovations News & Media
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure
NANJING, China, Oct. 22, 2024 /PRNewswire/ -- HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for "Allogeneic Human iPSC-derived cardiomyocytes (HiCM-188) administered via intramyocardial injection during coronary artery bypass graft surgery." Heart failure (HF) is a significant public health issue, affecting at least 7 million patients in the US and approHELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure
NANJING, China, Oct. 22, 2024 /PRNewswire/ -- HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for "Allogeneic Human iPSC-derived cardiomyocytes...
Top Business Services Companies
Frequently Asked Questions Regarding Help Stem Cell Innovations
HELP Therapeutics is a Chinese company focused on developing innovative and affordable cell therapy products aimed at treating degenerative diseases such as cardiovascular, bone metabolism, and ophthalmic disorders. The company is committed to its vision of enabling humans to live healthily up to 120 years by advancing the development of safe, reli... Read More